Influence of the glass packing on the contamination of pharmaceutical products by aluminum. Part I: Salts, glucose, heparin and albumin
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 15 (2-3) , 95-101
- https://doi.org/10.1016/s0946-672x(01)80050-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Aluminum Exposure and MetabolismCritical Reviews in Clinical Laboratory Sciences, 1997
- Aluminum in Enteral Nutrition Formulas and Parenteral SolutionsJournal of Toxicology: Clinical Toxicology, 1997
- Aluminum in parenteral solutions revisited—againThe American Journal of Clinical Nutrition, 1995
- Risk of Aluminum Accumulation in Patients With Burns and Ways to Reduce itJournal of Burn Care & Rehabilitation, 1994
- Aluminum Toxicity in Patients with Chronic Renal FailureTherapeutic Drug Monitoring, 1993
- The Aluminum Content of Parenteral Solutions: Current StatusPublished by Oxford University Press (OUP) ,1991
- Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intentThe American Journal of Clinical Nutrition, 1991
- Inadvertent Metal Loading of Critically Ill Patients with Acute Renal Failure by Human Albumin Solution Infusion TherapyJournal of Toxicology: Clinical Toxicology, 1988
- Evidence of Aluminum Loading in Infants Receiving Intravenous TherapyNew England Journal of Medicine, 1985
- Inadvertent Aluminum Administration during Plasma Exchange Due to Aluminum Contamination of Albumin-Replacement SolutionsNew England Journal of Medicine, 1985